The lysosomal storage disease market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). Lysosomal storage disease is caused due to the improper functioning of lysosomes. There are about 50 types of lysosomal storage diseases. The lysosomal storage disease market growth is driven by the increase in the rate of incidence of the disease, growth, and development in the diagnosis of disease, rise in the research and development for the treatment of the disease. Further, increasing awareness about lysosomal storage disease and the implementation of the orphan drug regulation which would assist in boosting the marketing and commercial profits for the pharmaceutical players in the market is also contributing to the industry growth.

Get Free Sample Copy @https://www.omrglobal.com/request-sample/lysosomal-storage-disease-market

The lysosomal storage disease market is driven by the growth in the incidence of the disease in the people. The National Gaucher Foundation survey suggests that there are more than 40 types of lysosomal storage and the disease affect an estimated 1 out of 7,700 people. The rising population and the prevalence of the disease contribute together to the highly increasing number of patients in the world. Another study which was conducted by the Mayo Clinic suggests that the incidence of the disease was in the range of 1 out of 4,000 to 1 out of 13,000 births.

Browse for Full Report Description@https://www.omrglobal.com/industry-reports/lysosomal-storage-disease-market

Market Segmentation

Global Lysosomal Storage Disease Market by Type

Gaucher Disease
Pompe Disease
Tay-Sachs Disease
Fabry Disease
Other (Cystinosis and Krabbe Disease)
Global Lysosomal Storage Disease Market by Treatment

Enzyme Replacement Therapy
Substrate Reduction Therapy
Stem Cell Transplant
Regional Analysis

North America
United States
Canada
Europe

UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific

China
India
Japan
Rest of Asia-Pacific
Rest of the World

Company Profiles

Actelion Pharmaceuticals, Ltd. (A Part of Johnson & Johnson Service, Inc.)
Alexion Pharmaceuticals, Inc.
Amicus Therapeutics, Inc.
AMO Pharma, Ltd.
Arena Pharmaceuticals, Inc.
BioMarin Pharmaceuticals, Inc.
Chiesi Farmaceutici SpA
Eli Lilly Co.
Horizon Therapeutics, Inc.
Leadiant Biosciences, Inc.
Pfizer, Inc.
Protalix Biotherapeutics, Inc.
Sanofi S.A.
Sigilon Therapeutics, Inc.
Takeda Pharmaceuticals Co. Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lysosomal-storage-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404